SLE patients had a significantly reduced percentage of B cells and also reduced proportions of CD19+IgD+CD27+ and CD19+IgD-CD27+ cells, with a clear shift to CD19+IgD-CD27- (DN) B cells. Here, CD19 is linked to systemic lupus erythematosus.